Latest news
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement - Psychiatric TimesPsychiatric Times · Wed, 05 Aug 2026 16:00:17 GMTGus Alva, MD, on Agitation, Psychosis, and Cognition in Alzheimer Disease - Psychiatric TimesPsychiatric Times · Fri, 31 Jul 2026 07:00:00 GMTLiBBY trial results show THC-CBD combo significantly reduces end-of-life dementia agitation - Bioengineer.orgBioengineer.org · Wed, 29 Jul 2026 07:00:00 GMTCBD and THC Reduce Dementia Agitation - Neuroscience NewsNeuroscience News · Tue, 28 Jul 2026 17:33:41 GMTPatrys Develops Fast-Acting Injectable Quetiapine for ICU Delirium Treatment with $2 Billion Market Potential - Kalkine MediaKalkine Media · Mon, 27 Jul 2026 07:00:00 GMT